210 related articles for article (PubMed ID: 25907200)
1. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
David G; Lim S; Gunnarsson C; Kocharian R; Roy S
J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
[TBL] [Abstract][Full Text] [Related]
2. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients.
Makhija D; Rock M; Ikeme S; Kuntze E; Epstein JD; Nicholson G; Price JS; Patel V
J Med Econ; 2017 Jun; 20(6):606-613. PubMed ID: 28287015
[TBL] [Abstract][Full Text] [Related]
3. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures.
Makhija D; Rock M; Xiong Y; Epstein JD; Arnold MR; Lattouf OM; Calcaterra D
J Med Econ; 2017 Jun; 20(6):565-573. PubMed ID: 28097913
[TBL] [Abstract][Full Text] [Related]
4. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery.
Price JS; Tackett S; Patel V
J Med Econ; 2015; 18(10):777-86. PubMed ID: 25934148
[TBL] [Abstract][Full Text] [Related]
5. Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients.
Ramirez MG; Niu X; Epstein J; Yang D
J Med Econ; 2018 Oct; 21(10):1041-1046. PubMed ID: 30112922
[TBL] [Abstract][Full Text] [Related]
6. Real-world outcomes of hemostatic matrices in cardiac surgery.
Tackett SM; Calcaterra D; Magee G; Lattouf OM
J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):1558-65. PubMed ID: 25245578
[TBL] [Abstract][Full Text] [Related]
7. Floseal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes.
Ramirez MG; Deutsch H; Khanna N; Cheatem D; Yang D; Kuntze E
Hosp Pract (1995); 2018 Oct; 46(4):189-196. PubMed ID: 29986148
[TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
9. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R
Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
[TBL] [Abstract][Full Text] [Related]
10. Hospital economic impact from hemostatic matrix usage in cardiac surgery.
Tackett SM; Sugarman R; Kreuwel HT; Alvarez P; Nasso G
J Med Econ; 2014 Sep; 17(9):670-6. PubMed ID: 24927164
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal versus Surgiflo.
Landi A; Gregori F; Marotta N; Delfini R
J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):139-43. PubMed ID: 26351870
[TBL] [Abstract][Full Text] [Related]
12. FLOSEAL Versus SURGIFLO in Lumbar Surgery: Similar Outcomes, Different Costs in a Matched Cohort Analysis.
Ye IB; Thomson AE; Smith RA; Pease TJ; Chowdhury N; Donahue J; Miseo V; Jauregui JJ; Cavanaugh DL; Koh EY; Ludwig SC
World Neurosurg; 2023 Jun; ():. PubMed ID: 37356481
[TBL] [Abstract][Full Text] [Related]
13. Real-world economic and clinical outcomes associated with current hemostatic matrix use in spinal surgery.
Danker W; Kelkar SS; Marston XL; Aggarwal J; Johnston SS
J Comp Eff Res; 2022 Dec; 11(17):1231-1240. PubMed ID: 36306241
[TBL] [Abstract][Full Text] [Related]
14. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures.
Gazzeri R; Galarza M; Alfier A
Surg Technol Int; 2012 Dec; 22():49-54. PubMed ID: 22915500
[TBL] [Abstract][Full Text] [Related]
15. Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial.
Murray S; Mendez A; Hopkins A; El-Hakim H; Jeffery CC; Côté DWJ
J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):3. PubMed ID: 29310703
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding.
MacDonald MH; Zhang G; Tasse L; Wang D; De Leon H; Kocharian R
J Mater Sci Mater Med; 2021 Sep; 32(10):127. PubMed ID: 34591193
[TBL] [Abstract][Full Text] [Related]
17. Gelatin Paste as an Alternative Cost-Effective Hemostatic Agent in Cranial Surgery: Doing More with Less.
Serrato-Avila JL; Navarro-Fernández JO; Hernández-Reséndiz R; Cacho-Díaz B; Reyes-Soto G; Monroy-Sosa A
World Neurosurg; 2019 Feb; 122():224-228. PubMed ID: 30415038
[TBL] [Abstract][Full Text] [Related]
18. Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review.
Echave M; Oyagüez I; Casado MA
BMC Surg; 2014 Dec; 14():111. PubMed ID: 25528250
[TBL] [Abstract][Full Text] [Related]
19. Perioperative outcomes and hospital costs associated with flowable gelatin hemostatic matrix for lumbar surgeries in real world hospital setting.
Wu B; Song K; Gong Q; Zhan H; Chen W; Wang Z
J Med Econ; 2019 Sep; 22(9):917-923. PubMed ID: 31124723
[No Abstract] [Full Text] [Related]
20. Intraoperative anaphylaxis secondary to intraosseous gelatin administration.
Luhmann SJ; Sucato DJ; Bacharier L; Ellis A; Woerz C
J Pediatr Orthop; 2013; 33(5):e58-60. PubMed ID: 23752162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
